Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR51050
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Majumdar, Abir; Burban, David; Muretta, Joseph; Thompson, Andrew; Engel, Tiffany; Rasmussen, Damien; Subrahmanian, Manu; Veglia, Gianluigi; Thomas, David; Levinson, Nicholas. "Allostery governs Cdk2 activation and differential recognition of CDK inhibitors." Nat. Chem. Biol. 17, 456-464 (2021).
PubMed: 33526892
Assembly members:
entity_1, polymer, 298 residues, Formula weight is not available
entity_RRC, non-polymer, 354.449 Da.
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pCDF-Duet
Entity Sequences (FASTA):
entity_1: MENFQKVEKIGEGTYGVVYK
ARNKLTGEVVALKKIRLDTE
TEGVPSTAIREISLLKELNH
PNIVKLLDVIHTENKLYLVF
EFLHQDLKKFMDASALTGIP
LPLIKSYLFQLLQGLAFCHS
HRVLHRDLKPQNLLINTEGA
IKLADFGLARAFGVPVRTYT
HEVVTLWYRAPEILLGCKYY
STAVDIWSLGCIFAEMVTRR
ALFPGDSEIDQLFRIFRTLG
TPDEVVWPGVTSMPDYKPSF
PKWARQDFSKVVPPLDEDGR
SLLSQMLHYDPNKRISAKAA
LAHPFFQDVTKPVPHLRL
Data type | Count |
13C chemical shifts | 419 |
15N chemical shifts | 127 |
1H chemical shifts | 127 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | Cdk2 | 1 |
2 | Roscovitine | 2 |
Entity 1, Cdk2 298 residues - Formula weight is not available
1 | MET | GLU | ASN | PHE | GLN | LYS | VAL | GLU | LYS | ILE | ||||
2 | GLY | GLU | GLY | THR | TYR | GLY | VAL | VAL | TYR | LYS | ||||
3 | ALA | ARG | ASN | LYS | LEU | THR | GLY | GLU | VAL | VAL | ||||
4 | ALA | LEU | LYS | LYS | ILE | ARG | LEU | ASP | THR | GLU | ||||
5 | THR | GLU | GLY | VAL | PRO | SER | THR | ALA | ILE | ARG | ||||
6 | GLU | ILE | SER | LEU | LEU | LYS | GLU | LEU | ASN | HIS | ||||
7 | PRO | ASN | ILE | VAL | LYS | LEU | LEU | ASP | VAL | ILE | ||||
8 | HIS | THR | GLU | ASN | LYS | LEU | TYR | LEU | VAL | PHE | ||||
9 | GLU | PHE | LEU | HIS | GLN | ASP | LEU | LYS | LYS | PHE | ||||
10 | MET | ASP | ALA | SER | ALA | LEU | THR | GLY | ILE | PRO | ||||
11 | LEU | PRO | LEU | ILE | LYS | SER | TYR | LEU | PHE | GLN | ||||
12 | LEU | LEU | GLN | GLY | LEU | ALA | PHE | CYS | HIS | SER | ||||
13 | HIS | ARG | VAL | LEU | HIS | ARG | ASP | LEU | LYS | PRO | ||||
14 | GLN | ASN | LEU | LEU | ILE | ASN | THR | GLU | GLY | ALA | ||||
15 | ILE | LYS | LEU | ALA | ASP | PHE | GLY | LEU | ALA | ARG | ||||
16 | ALA | PHE | GLY | VAL | PRO | VAL | ARG | THR | TYR | THR | ||||
17 | HIS | GLU | VAL | VAL | THR | LEU | TRP | TYR | ARG | ALA | ||||
18 | PRO | GLU | ILE | LEU | LEU | GLY | CYS | LYS | TYR | TYR | ||||
19 | SER | THR | ALA | VAL | ASP | ILE | TRP | SER | LEU | GLY | ||||
20 | CYS | ILE | PHE | ALA | GLU | MET | VAL | THR | ARG | ARG | ||||
21 | ALA | LEU | PHE | PRO | GLY | ASP | SER | GLU | ILE | ASP | ||||
22 | GLN | LEU | PHE | ARG | ILE | PHE | ARG | THR | LEU | GLY | ||||
23 | THR | PRO | ASP | GLU | VAL | VAL | TRP | PRO | GLY | VAL | ||||
24 | THR | SER | MET | PRO | ASP | TYR | LYS | PRO | SER | PHE | ||||
25 | PRO | LYS | TRP | ALA | ARG | GLN | ASP | PHE | SER | LYS | ||||
26 | VAL | VAL | PRO | PRO | LEU | ASP | GLU | ASP | GLY | ARG | ||||
27 | SER | LEU | LEU | SER | GLN | MET | LEU | HIS | TYR | ASP | ||||
28 | PRO | ASN | LYS | ARG | ILE | SER | ALA | LYS | ALA | ALA | ||||
29 | LEU | ALA | HIS | PRO | PHE | PHE | GLN | ASP | VAL | THR | ||||
30 | LYS | PRO | VAL | PRO | HIS | LEU | ARG | LEU |
Entity 2, Roscovitine - C19 H26 N6 O - 354.449 Da.
1 | RRC |
sample_1: Cyclin Dependent Kinase 2, [U-13C; U-15N; U-2H], 350 uM; Roscovitine 1 mM; D2O, [U-2H], 10%; NaPO4 10 mM; NaCl 140 mM; DTT 10 mM; MgCl2 10 mM
sample_2: Cyclin Dependent Kinase 2, [U-15N]-Lys, 300 uM; Roscovitine 1 mM; D2O, [U-2H], 10%; NaPO4 10 mM; NaCl 140 mM; DTT 10 mM; MgCl2 10 mM
sample_3: Cyclin Dependent Kinase 2, [U-15N]-Leu, 300 uM; Roscovitine 1 mM; D2O, [U-2H], 10%; NaPO4 10 mM; NaCl 140 mM; DTT 10 mM; MgCl2 10 mM
sample_4: Cyclin Dependent Kinase 2, [U-15N]-Phe, 300 uM; Roscovitine 1 mM; D2O, [U-2H], 10%; NaPO4 10 mM; NaCl 140 mM; DTT 10 mM; MgCl2 10 mM
sample_5: Cyclin Dependent Kinase 2, [U-15N]-Val, 300 uM; Roscovitine 1 mM; D2O, [U-2H], 10%; NaPO4 10 mM; NaCl 140 mM; DTT 10 mM; MgCl2 10 mM
sample_6: Cyclin Dependent Kinase 2, [U-15N]-Ile, 300 uM; Roscovitine 1 mM; D2O, [U-2H], 10%; NaPO4 10 mM; NaCl 140 mM; DTT 10 mM; MgCl2 10 mM
sample_7: Cyclin Dependent Kinase 2, [U-15N]-Tyr, 300 uM; Roscovitine 1 mM; D2O, [U-2H], 10%; NaPO4 10 mM; NaCl 140 mM; DTT 10 mM; MgCl2 10 mM
sample_conditions_1: ionic strength: 0.2 M; pH: 7.4; pressure: 1 atm; temperature: 298.1 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
3D HNCA | sample_1 | isotropic | sample_conditions_1 |
3D HN(CO)CA | sample_1 | isotropic | sample_conditions_1 |
3D HNCACB | sample_1 | isotropic | sample_conditions_1 |
3D HNCO | sample_1 | isotropic | sample_conditions_1 |
3D HN(CA)CO | sample_1 | isotropic | sample_conditions_1 |
3D HN(CO)CACB | sample_1 | isotropic | sample_conditions_1 |
2D 1H-15N TROSY | sample_3 | isotropic | sample_conditions_1 |
2D 1H-15N TROSY | sample_4 | isotropic | sample_conditions_1 |
2D 1H-15N TROSY | sample_5 | isotropic | sample_conditions_1 |
2D 1H-15N TROSY | sample_7 | isotropic | sample_conditions_1 |
2D 1H-15N TROSY | sample_6 | isotropic | sample_conditions_1 |
2D 1H-15N TROSY | sample_7 | isotropic | sample_conditions_1 |
TOPSPIN - collection
NMRPipe - processing
NMRFAM-SPARKY - chemical shift assignment
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks